VIVUS Inc. (VVUS) belongs to the “Healthcare” sector with an industry focus on “Biotechnology”, with Mr. Seth H. Z. Fischer as Chief Exec. Officer and Director.
The company has been one of the biggest innovators in “Biotechnology” employing approximately 65 full time employees.
- The stock added in the prior trading session by 7.37%, closing at the stock price of $0.94.
- Currently, the market capitalization of VIVUS Inc. (VVUS) is 98.99 Million.
- VVUS has a 1-year high price of $ 1.47 and 1-year low price of $0.86.
- The number of shares currently held by investors is 105.81 Million.
- The number of shares traded in the last trading session was 3.04 Million.
The company reported an impressive total revenue of 124.26 Million in the last fiscal year.
If you look at the company’s income statement over the past years, you will see that the company is constantly posting gross profit: In 2014, VVUS earned gross profit of 80.79 Million, in 2015 61.27 Million gross profit, while in 2016 VIVUS Inc. (VVUS) produced 113.66 Million profit.
Currently the shares of VIVUS Inc. (VVUS) has a trading volume of 3.04 Million shares, with an average trading volume of 1370 shares – with shares dropping to a 52 week low of $0.86, and the company’s shares hitting a 52 week high of $ 1.47.
Looking at the current price of the stock and the 52 week high and low, it suggests that the stock is likely to go Up in the future.
Earnings per share (EPS) breaks down the profitability of the company on a single share basis, and for VIVUS Inc. the EPS stands at -0.13 for the previous quarter, while the analysts predicted the EPS of the stock to be -0.13, suggesting the stock fell short of the analysts’ expectations.
Another critical number in evaluating a stock is P/E or the price to earnings ratio.
Currently the P/E of VIVUS Inc. stands at 3.09. Looking at this figure it suggests that the shares of VIVUS Inc. (VVUS) may be overvalued, however, this can also depend upon the situation of the market; if the market is strong then it could suggest that VIVUS Inc. (VVUS) is a good investment, however if the market is weaker then it could suggest that the shares are undervalued.
The TTM operating margin is 49.6%. The return on invested capital at 21.4%, which is good, compared to its peers.
The Free Cash Flow or FCF margin is 0%, which means that the business has healthy reserve funds for contingencies that may arise.
Stock is currently moving with a negative distance from the 200 day simple moving average of approximately -17.8%, and has a poor year to date (YTD) performance of -18.65% which means the stock is constantly subtracting to its value from the previous fiscal year end price.
The stock diminished about -38% in the past 5 years, this negative value indicates that the stock constantly going down in previous years as well.
The target price for VIVUS Inc. (VVUS) is $2.15/share according to the consensus of analysts working on the stock, with an expected EPS of $-0.13/share for the current quarter.
The company’s expected revenue in the current quarter to be 16 Million, seeing a projected current quarter growth of -44.4%, and per annum growth estimates over the next 5 year period of around 0.8%.